Results 111 to 120 of about 12,119 (223)

Circulating Memory T Follicular Helper Cells in Patients with Neuromyelitis Optica/Neuromyelitis Optica Spectrum Disorders

open access: yesMediators of Inflammation, 2016
Objective. This study aimed to examine the potential role of memory T follicular helper (Tfh) cells in patients with neuromyelitis optica/neuromyelitis optica spectrum disorders (NMO/NMOSD). Methods.
Xueli Fan   +6 more
doaj   +1 more source

Diagnosis of multiple sclerosis: progress and challenges [PDF]

open access: yes, 2017
The diagnosis of multiple sclerosis (MS) is based on typical neurological symptoms and signs along with evidence of dissemination of central nervous system (CNS) lesions in space and time.
Brownlee, W   +3 more
core   +1 more source

Lingual Dyskinesia as the Presenting Feature of Acquired Demyelinating Syndrome: A Case Report and Review of Differential Diagnoses

open access: yes
Journal of Paediatrics and Child Health, EarlyView.
Briana Davis   +3 more
wiley   +1 more source

Neuromyelitis Optica Spectrum Disorders – from pathophysiology to treatment

open access: yesQuality in Sport
Neuromyelitis optica spectrum disorders (NMOSD) are a group of autoimmune diseases characterized by severe, inflammatory attacks predominantly affecting the optic nerves and spinal cord and central nervous system.
Jessica Adriana Kałuża   +9 more
doaj   +1 more source

Neuro-ophthalmic manifestation of neuromyelitis optica spectrum disorders

open access: yesChinese Journal of Contemporary Neurology and Neurosurgery, 2014
Neuromyelitis optica spectrum disorders (NMOSDs) include classic neuromyelitis optica (NMO), opticospinal multiple sclerosis (OSMS), limited form of NMO and isolated optic neuritis or myelitis accompanied by either systemic autoimmune diseases or ...
Xiao-jun ZHANG, Xian-hao XU
doaj  

Demyelinating syndrome in SLE: review of different disease subtypes and report of a case series

open access: yesReumatismo, 2017
Demyelinating syndrome (DS) is a rare manifestation of systemic lupus erythematosus (SLE) (1%) with high clinical heterogeneity and potentially severe prognosis. It can represent a diagnostic and therapeutic challenge for clinicians.
E. Chessa   +4 more
doaj   +1 more source

Extensive myelitis associated with anti-NMDA receptor antibodies. [PDF]

open access: yes, 2013
International audienceBACKGROUND: Encephalitis with anti-N-methyl-D-aspartate receptor antibodies (anti-NMDAR-Ab) is a rapid-onset encephalitis including psychosis, seizures, various movement disorders and autonomic system disturbances. CASE PRESENTATION:
Baille, Guillaume   +7 more
core   +2 more sources

Pain in patients with neuromyelitis optica spectrum disorders

open access: yesНеврология, нейропсихиатрия, психосоматика
Neuromyelitis optica spectrum disorders (NMOSD) are a group of chronic autoimmune diseases of the central nervous system with a relapsing course. Unfortunately, the symptoms of exacerbation cannot always be completely stopped, and in addition to motor ...
E. S. Novikova, A. S. Kotov, S. V. Kotov
doaj   +1 more source

Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disorders

open access: yesMultiple Sclerosis Journal - Experimental, Translational and Clinical, 2018
Background Pain is a frequent symptom in aquaporin-4-immunoglobulin-G-positive neuromyelitis optica spectrum disorders (AQP4-IgG-pos. NMOSD). Data on pain in myelin-oligodendrocyte-glycoprotein-immunoglobulin-G autoimmunity with a clinical NMOSD ...
Susanna Asseyer   +7 more
doaj   +1 more source

An update on the evidence for the efficacy and safety of rituximab in the management of neuromyelitis optica

open access: yesTherapeutic Advances in Neurological Disorders, 2016
Neuromyelitis optica spectrum disorders (NMOSDs) is a new concept which includes classical neuromyelitis optica (NMO) and partial forms of NMO such as recurrent optic neuritis with positive aquaporin-4 antibodies (AQP4) or brainstem symptoms (intractable
Nicolas Collongues, Jérôme de Seze
doaj   +1 more source

Home - About - Disclaimer - Privacy